Previous 10 | Next 10 |
I investigate the reasoning behind Anvex Life Sciences' wild share price ride over the last year. The company’s lead compound Anavex 2-73 has a favorable safety profile, but what does the data show? I briefly touch on the companies Parkinson's disease therapy. For fur...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With few updates from the company in recent weeks, it’s no shock that shares in Cassava Sciences (NASDAQ: SAVA ) haven’t made many big moves lately. Sure, SAVA stock did experience a brief slide late mon...
Seeking Alpha longs have warned that increasing short positions in Cassava Sciences stock could result in a “short squeeze.”. For at least several days, comments on Seeking Alpha have disclosed that retail longs are receiving telephone calls from their brokers, asking if...
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in shares of Cassava Sciences, Inc. (NASDAQ: SAVA). Investors who purchased shares of Cassava Sciences, Inc. (NASDAQ: SAVA) prior to February 2021 a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips On the morning of Jan. 20, 2022, Texas-based clinical-stage biotechnology company Cassava Sciences (NASDAQ: SAVA ) was trending on financial message board StockTwits as traders were buzzing about this cont...
Biotech stocks have been hammered back to back for two years in a row now. The last time the SPDR ETF suffered a drop of 15% or more was in 2018, and the fund followed it up with a 33% increase in 2019. It dropped more than 15% in 2016 and followed that up with […] For further detail...
Investors were all spooked today with Dow plummeting more than 500 points. The primary cause can be attributed to inflation fears, disappointing earnings, and booming bond yields. Tech stocks drove the Dow down with the NASDAQ skidding 2.6 percent and the S&P 500 index falling 1.8 percent...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While a risky area, there’s a lot of opportunity when it comes to biotech stocks. With the right combination of due diligence and trading agility, you can find investments/trades that can result in incredible returns...
If you’re like most traders in the stock market today, penny stocks are something to get familiar with. Now, keep in mind, I say “traders” and not “investors” for a reason. In many cases, these cheap stocks fluctuate rapidly in price more than your ave...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Sciences (NASDAQ: SAVA ) stands to gain a good deal this year. This will all depend on the company’s Phase 3 clinical trials progress in the results on actual patients with Alzheimer’s disease. S...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...
A look at the top 10 most actives in the United States Aptevo Therapeutics Inc. (APVO) rose 45.1% to $0.486 on volume of 64,992,551 shares Verb Technology Company Inc. (VERB) rose 3.5% to $0.1205 on volume of 54,410,242 shares NVIDIA Corporation (NVDA) fell 4.4% to $120.752 on volume of 4...